← Open Payments lookup

NPI 1285909234: Open Payments

NPI 1285909234. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$227 in 14 payments from 8 companies in 2025. Trend: 2023 $1,402 · 2024 $846 · 2025 $227

Food & beverage: $227
CompanyPaymentsAmount
PFIZER INC.4$60
Novo Nordisk Inc3$51
GlaxoSmithKline, LLC.2$27
Dexcom, Inc.1$23
Inspire Medical Systems, Inc.1$20
SANOFI PASTEUR INC.1$17
Bayer Healthcare Pharmaceuticals Inc.1$15
Merck Sharp & Dohme LLC1$14

Products named: Ozempic, NURTEC ODT, TRELEGY ELLIPTA, Dexcom G6 Transmitter, INSPIRE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Kerendia, GARDASIL 9.